StageBio, a provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research, has appointed David Bruning as Chief Executive Officer.   Having served on the StageBio Board of Directors for the past five years in addition to previously being a longstanding customer of StageBio, Bruning possesses a deep understanding of the company, its strategic priorities and the evolving needs of its customers. Bruning brings over 25 years of lea...